-- Sino Biopharmaceutical (HKG:1177) appointed Kang Xiaoyan as its chief medical officer, according to a Hong Kong bourse filing Tuesday.
Kang has over twenty five years of experience in clinical practice and drug research and development, Sino Biopharmaceutical said.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Enterprise Products Partners (EPD) kicked off 2026 with Q1 earnings per unit of $0.68, missing consensus by $0.05, though adjusted EBITDA of $2.7B rose 10% Y/Y, reflecting strong underlying performance. Volume growth remained robust across key segments, with record natural gas processing inlet volumes of 8.3 bcf/d up 7% Y/Y and NGL pipeline volumes of 4.9 mmb/d up 10% Y/Y. Growth opportunities in natural gas processing look healthy, with plans for two additional processing plants in 2027 to increase total capacity by 12% and capture growing Permian production. Management noted natural gas and NGL production growth is expected to be 1.6x that of crude oil production growth. The company sees 2026 growth capex of $2.3B-$2.6B, down from original plans of $2.5B-$2.9B. With recent projects in service, we see EPD entering "harvesting mode" with meaningful free cash flow expansion ahead. We think demand for midstream services is increasingly fueled by data center expansion requiring more natural gas pipeline capacity.
American Homes 4 Rent (AMH) has an average rating of overweight and mean price target of $34.62, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)